Three-year follow-up of galantamine therapy for Alzheimer's disease: Efficacy and tolerability in open-label extension studies

Three-year follow-up of galantamine therapy for Alzheimer's disease: Efficacy and tolerability in open-label extension studies

Détails bibliographiques
Auteurs principaux:	Wilcock, G, Truyen, L
Format:	Journal article
Publié:	2002